drugset / Trial / NCT06346522

Gabapentin Versus Trospium Chloride for Prevention of a Catheter-related Bladder Discomfort Inside the ICU

NCT06346522

Phase 4 Completed 120 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindPrevention

Summary

Catheter-related bladder discomfort (CRBD) is a frequent complaint after urinary bladder catheterization which is commonly done in the perioperative period. CRBD shows similar symptoms to overactive bladder (OAB); so, drugs used for the management of OAB could influence symptoms of CRBD. Trospium chloride and gabapentin are effective in managing patient with OAB even the resistant cases. We will evaluate and compare the efficacy of both oral trospium and gabapentin on prevention of CRBD in the postoperative period in the ICU in in patients undergoing spinal surgery and requiring intraoperative catheterization of the urinary bladder.

Timeline

Start
2024-04-10
Primary completion
2024-09-01
Completion
2024-09-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 400 mg Oral
Comparator Trospium Small molecule 60 mg Oral

Indications

No indication recorded.